Axios VeritasAxios Veritas

FDA names Tracy Høeg as interim head of drug evaluation division

  1. HOME
  3. ENTERTAINMENT
  5. FDA names Tracy Høeg as interim head of drug evaluation division
FDA names Tracy Høeg as interim head of drug evaluation division

December 3 The U.S. Food and Drug Administration announced on Wednesday that Tracy Beth Heg has been named the acting director of the Center for Drug Evaluation and Research. This appointment comes shortly after Richard Pazdur, the agency's longtime oncology leader, announced his retirement just weeks into his tenure.

Pazdur had stepped into the role on November 11, following the resignation of George Tidmarsh, who left amid significant concerns regarding his personal conduct.

Author: Caleb Jennings

Share

US FDA dismisses director of over-the-counter drugs office
US FDA dismisses director of over-the-counter drugs office

1 days ago 2 min read HEALTH

169
FDA names Tracy Høeg as interim head of drug evaluation division
FDA names Tracy Høeg as interim head of drug evaluation division

1 days ago 1 min read ENTERTAINMENT

367
FDA drug chief hints at potential departure as agency chaos intensifies
FDA drug chief hints at potential departure as agency chaos intensifies

1 days ago 3 min read HEALTH

853
Richard Padzur to depart FDA after recent CDER leadership change
Richard Padzur to depart FDA after recent CDER leadership change

1 days ago 2 min read POLITICS

176
Top FDA drug regulator to leave position shortly after starting
Top FDA drug regulator to leave position shortly after starting

2 days ago 4 min read BUSINESS

20